Diet-Induced Obesity in Mice Reduces the Maintenance of Influenza-Specific CD8+ Memory T Cells by Karlsson, Erik A. et al.
The Journal of Nutrition
Nutritional Immunology
Diet-Induced Obesity in Mice Reduces the
Maintenance of Influenza-Specific CD8+
Memory T Cells1,2
Erik A. Karlsson, Patricia A. Sheridan, and Melinda A. Beck*
Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599-7461
Abstract
Obesity has been associated with increasing the risk for type 2 diabetes and heart disease, but its influence on the
immune response to viral infection is understudied. Memory T cells generated during a primary influenza infection are
important for protection against subsequent influenza exposures. Previously, we have demonstrated that diet-induced
obese (DIO) mice have increased morbidity and mortality following secondary influenza infection compared with lean
mice. To determine whether the problem resided in a failure to maintain functional, influenza-specific CD8+ memory T
cells, male DIO and lean mice were infected with influenza X-31. At 84 d postinfection, DIO mice had a 10% reduction in
memory T cell numbers. This reduction may have resulted from significantly reduced memory T cell expression of
interleukin 2 receptor b (IL-2Rb, CD122), but not IL-7 receptor a (CD127), which are both required for memory cell
maintenance. Peripheral leptin resistance in the DIO mice may be a contributing factor to the impairment. Indeed, leptin
receptor mRNA expression was significantly reduced in the lungs of obese mice, whereas suppressor of cytokine
signaling (Socs)1 and Socs3mRNA expression were increased. It is imperative to understand how the obese state alters
memory T cells, because impairment in maintenance of functional memory responses has important implications for
vaccine efficacy in an obese population. J. Nutr. 140: 1691–1697, 2010.
Introduction
Obesity is a major global public health problem. Although humans
are fairly well adapted to periods of reduced food intake, they are
poorly adapted to overnutrition (1). Obesity can lead to serious
health consequences and, subsequently, increases in health care
requirements and economic burden. Resulting from increased
energy intake and decreased expenditure (2), obesity has been
linked to numerous health problems and chronic diseases (3,4).
These comorbidities associatedwith obesity have been attributed to
hormonal and metabolic changes related to increases in adipose
tissue mass (5,6). Obesity is an independent risk factor for cardio-
vascular disease, type 2 diabetes, hypertension, arthritis, sleep
apnea, and cancer (reviewed in 7); however, its effects on suscep-
tibility to infection are poorly understood. In a hospital setting, obese
patients are more likely to develop secondary infections and obese
individuals are at increased risk for community-related respiratory
tract infections (8–11). Studies in diet-induced obese (DIO)3 animal
models have shown obese mice had lower levels of mitogen-
induced interleukin (IL)-2, although interferon (IFN)-g and
IL-4 production increased (12). Additionally, obese mice have
impaired dendritic cell (DC) function and altered T cell
responsiveness (13–19). Recently, obese individuals have been
found to be at a greater risk of morbidity and mortality from
infection with pandemic novel influenza H1N1 strain (20,21).
At this time, it is unclear how obesity can result in a greater risk
from H1N1 infection.
Influenza is a highly contagious, seasonal respiratory illness
caused by the influenza virus. In any given year, 5–15% of the
world population is infected with influenza virus, resulting in 3–
5 million cases of severe illness and 500,000 deaths from
influenza and influenza-related complications (22,23). Because
of the propensity of influenza virus surface proteins to change
each year, an antibody-based vaccine may be effective for one
year but not the next (24). However, memory T cells target
internal influenza virus proteins, which have little variation year
to year (25). Therefore, a vaccine that targets expanding
memory T cells may be more effective than a traditional
antibody-based vaccine.
Previously, we showed that diet-induced obesity in mice
significantly reduced the memory T cell response to secondary
viral challenge, resulting in increased morbidity and mortality
(24). To understand how obesity contributes to a poor response
to secondary viral challenge, we examined the ability of DIO
mice to maintain influenza-specific memory CD8+ T cells.
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Materials and Methods
Animals. Weanling, male C57BL/6J mice were obtained from Jackson
Laboratories and housed at the University of North Carolina Animal
Facility, which is fully accredited by the American Association for
Accreditation of Laboratory Animal Care. Animals were housed 4/cage
under pathogen-free/viral Ab-free conditions and maintained under
protocols approved by the Institutional Animal Use and Care Commit-
tee. Mice were randomized to receive either a low-fat diet (Research
Diets; D12329) (n = 40) or a high-fat/high-sucrose diet (D12331) (n =
40) for 20 wk. The dietary composition was previously described by
Surwit et al. (25,26). Previous studies in our laboratory (27) and others
(28,29) have confirmed that these diets result in significant diet-induced
obesity in these mice.
Influenza viruses and infection. Mouse-adapted influenza virus strain
X-31 (H3N2) was grown in the allantoic fluid of embryonated hen’s
eggs. Influenza X-31 is a mouse-adapted, sublethal recombinant influ-
enza virus (30). The X-31 strain has been shown to produce memory T
cells able to prevent a lethal infection with a secondary influenza
infection (31). For infection, following 20 wk of the diets, lean and obese
mice were anesthetized intraperitoneally with ketamine/xylazine and
subsequently inoculated intranasally with 300 EID50 live X-31 virus in
30 mL sterile PBS. Mice were maintained on the diets. By d 33
postinfection (p.i.), no virus was detected in the lungs of either lean or
obese mice, demonstrating clearance of the infection (data not shown).
Quantitation of lung mRNA cytokine levels. Lung and spleen samples
were collected on d 33 and 84 p.i. and total RNA was isolated using the
TRIzol method. RTwas carried out with Superscript II First Strand Synthesis
kit (Invitrogen) using oligo (dT) primers. Following previously described
methods for quantitative real-time PCR (27), mRNA levels for murine IL-6
(Il6), and tumor necrosis factor (Tnfa) and Gapdh were determined
using previously described primer/probe sets and mRNA levels for Il15
(Mm00434210_m1), Il7 (Mm00434291_m1), IL2rb (Mm00434264_m1),
leptin receptor (Lepr; Mm00440181_m1), suppressor of cytokine signaling
(Socs1; Mm00782550_s1), Socs3 (Mm00545913_s1), and Actb
(Mm01205647_g1) were determined using TaqMan Gene Expression
assays (Applied Biosystems).
Isolation of cells from the lungs, spleen, and draining lymph
node. As previously described (32), lungs from lean and obese mice were
removed and digested in HBSS (with Ca andMg) supplemented with 160
kU/L Collagenase type 1 (Worthington). Spleen and draining lymph node
(mediastinal) cells were isolated in unsupplemented HBSS. Samples were
processed into single-cell suspensions by mechanical agitation of a
Stomacher (Seward) and strained through a 40-mm nylon filter. Cells
were subjected to RBC lysis using ACK lysis buffer for 5 min at room
temperature, washed, counted then analyzed by flow cytometry.
Flow cytometry. At least 1 3 106 cells were stained with fluorescein
isothiocyanate-anti-CD44, Pacific Blue-anti-CD62L (eBioscience) and
peridinin-chlorophyll-protein complex-anti-CD8a (BD Biosciences).
CD8+ T cells specific for the major epitope of the A/PR/8 nucleoprotein
were identified using a phycoerythrin-labeled DbNP366–374 tetramer.
Nonspecific tetramer staining was analyzed using an irrelevant tetramer
toward herpes simplex virus. Samples were analyzed on a Cyan ADP
flow cytometer (Beckman Coulter) and data were analyzed using FlowJo
software (TreeStar).
Statistical analysis. Nonparametric data were analyzed using the
Kruskal-Wallis test (a = 0.05). Normally distributed data were analyzed
by 2-way ANOVAwith diet and day p.i. as main effects. Student’s t test
was used for post-hoc comparisons between the dietary groups and the
days p.i. Differences were considered significant at P , 0.05. Statistical
analyses were performed using JMP Statistical Software (SAS Institute).
Results
DIO mice have significantly increased weight compared
with lean controls. At d 33 p.i., DIO mice weighed ~20 g more
(57.3 6 0.5 g) than their lean counterparts (37.3 6 0.8 g). At d
84 p.i., lean mice had gained ~5 g of weight from d 33; however,
lean mice still weighed ~15 g less (43.9 6 1.2 g) than their DIO
counterparts (56.2 6 1.3 g).
Influenza-specific central memory T cells increase over
time in the lung, spleen. Following a primary influenza
infection, a small population of influenza-specific central mem-
ory T (TCM) cells remain in secondary lymphoid tissues, which
includes the bronchiole-associated lymphoid tissue of the lungs.
In the lungs of both lean and obese mice, percent (Fig. 1A) but
not number (Fig. 1B) of TCM cells increased over time. The lean
and obese groups did not differ. In contrast, although percentage
of TCM cells increased in the spleen of both groups over time
(Fig. 1C), at d 84 p.i., obese mice had significantly more TCM in
the spleen compared with lean controls (Fig. 1D).
DIO mice maintain significantly reduced numbers of
influenza-specific CD8+ effector memory T cells in the
lungs. Following primary influenza infection, a population of
influenza-specific effector memory T (TEM) cells is maintained in
the lung to more rapidly respond to the next encounter with an
influenza virus. At d 33 post X-31 infection, both lean and obese
mice had populations of influenza-specific TEM cells in the lung
(Fig. 2A). In both the lean and obese mice, population percent
and number of TEM cells declined over time; however, the DIO
mice had a greater percent loss of TEM cell numbers, resulting in
a significant decrease in TEM cell numbers in the lungs of obese
mice compared with lean controls at d 84 p.i. (Fig. 2B,C). In
lymph nodes and spleen, the number of TEM decreased over time
in both the lean and obese mice; however, the 2 dietary groups
did not differ (data not shown).
CD122 (IL-2Rb) expression is significantly reduced on
influenza-specific TEM cells in the lungs of obese mice. In
both lean and obese mice, the percentage of TEM cells expressing
CD122 increased over time; however, at d 33 p.i., the percentage
of TEM cells expressing CD122 was significantly lower in the
lungs of obese mice compared with lean controls (Fig. 3A,B). In
addition to reduced percentage of cells expressing CD122, mean
FIGURE 1 Percentage (A,C ) and number (B,D) of influenza-specific
TCM in lung (A,B) and spleen (C,D) of lean and obese mice at d 33 and
84 p.i. TCM (CD8
+/DbNP366–74
+/CD44+/CD62L+) were identified using
flow cytometry. Data are means + SEM, n = 6. Symbols indicate
differences (P , 0.05): * vs. lean; § vs. d 33.
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fluorescence intensity of CD122 was also significantly lower on
TEM cells in the lungs of obese mice (Fig. 3C). Lung CD122
mRNA expression did not differ between obese and lean mice
(data not shown).
Obese mice have altered expression of Il15 and Il7 mRNA
in the lungs post primary infection. IL-7 and IL-15 are the
cytokines responsible for the homeostasis and survival of
memory T cells. In the lungs of obese mice, Il15 mRNA
expression at d 84 p.i. was ~3 times greater than in lean controls
(Table 1). In contrast, expression of Il7 mRNAwas 50% lower
at d 33 in the lungs of obese mice compared with lean controls.
Interestingly, in both lean and obese mice, expression of Il7
mRNA significantly increased over time.
Leptin receptor expression is reduced and Socs1 and
Socs3 expression is increased in the lungs of obese mice.
In the lungs of obese mice, Lepr mRNA expression was
significantly less than in lean mice at both d 33 and 84 p.i.
Lepr expression increased in the lungs of lean mice by d 84 post
X-31 infection; however, expression did not increase in the lungs
of obese mice. Additionally, expression of Socs1 and Socs3
significantly increased in the lungs of obese mice at d 84 p.i.
(Table 1).
The lungs of obese mice have significantly increased
inflammation in the absence of viral infection. Following
clearance of the X-31 infection at d 33 p.i., mRNA expression of
Tnfa but not Il6 significantly increased in the lungs of obese mice
compared with lean controls. At d 84 p.i., mRNA expression of
both Tnfa and Il6 significantly increased (Table 1).
Discussion
Avaccine that promotes a robust memory B cell antibody-based
response to the surface proteins of 1 strain of influenza could be
ineffective for a strain encountered the next season expressing
different surface proteins (33). However, there are several
internal viral proteins that are highly conserved among influenza
viruses and therefore do not experience the mutations seen with
the external proteins. Although these internal proteins do not
generate an effective antibody response because of their lack of
accessibility to antibodies, the cell-mediated immune response
can recognize these proteins. Therefore, memory T cells generated
during a primary influenza infection can target these internal
proteins common to influenza strains, making them effective
against encounters with heterologous virus stains. The ability to
generate functional memory T cells, either during a primary
infection or by vaccination, has proven to be protective against
potentially lethal influenza strains exhibiting completely different
surface antigens (34). Following viral clearance, contraction of
activated CD8+ T cells results in influenza-specific memory cells
representing ~5–10% of effector CD8+ T cells found at the peak
of expansion during primary infection (35,36).These long-lived
memory cells can rapidly respond to a secondary infection with
influenza virus.
Although the exact definitions are still controversial, memory
T cells established after infection can be divided into 2 subsets:
TCM, which preferentially localize to the lymphoid tissues, and
TEM, which are found mainly in peripheral sites of infection
(37,38). Numbers of TCM in lymphoid sites appear to remain
relatively constant, if not slightly increased, whereas the number
of TEM at peripheral sites steadily decreases in the months after
pathogen clearance. Although both lean and obese mice dem-
onstrated the expected increase in percent TCM and decrease in
TEM, the TEM in the lungs of the obese animals declined at a
significantly faster pace, resulting in a 10% reduction in the
numbers of TEM present compared with the lean controls. This
reduction in the numbers of influenza-specific TEM in the lungs
of obese mice has major health implications, because the
protective capacity from a secondary infection can be directly
linked to the number of pathogen-specific memory T cells
present in the tissue prior to secondary infection (39). Therefore,
as we have already observed a decrease in protective capacity in
influenza-specific memory T cells in obese mice (24), a reduction
in numbers of these cells could decrease protection even further.
Memory cells persist under normal conditions by undergoing
intermittent cell division, called bystander proliferation, about
once every 2 wk (40). Originally, the maintenance and survival
of memory T cells was thought to be mediated by signals arising
from contact with depots of persistent antigens; however,
memory cells have been shown to survive not only in the
absence of antigen but also in the absence of major histocom-
patibility complex molecules (41,42). Survival of memory cells
now appears to be maintained by members of the common
gamma chain (gc) family of cytokines, IL-15, and IL-7.
IL-15 is essential for the regulation of slow, intermittent basal
homeostatic proliferation of antigen-specific CD8+ memory T
cells (43). Viral challenge of IL152/2 and IL-15Ra2/2mice show
that IL-15 is dispensable for the generation of antigen-specific
FIGURE 2 Percentage (A,B) and number (C ) of
influenza-specific CD8+ TEM in lungs of lean
and obese mice at d 33 and 84 p.i. TEM (CD8
+/
DbNP366–74
+/CD44+/CD62L2) were identified using
flow cytometry. In B, data were obtained on d
84 p.i. Data are means + SEM, n = 6. Symbols
indicate differences (P , 0.05): * vs. lean; § vs.
d 33.
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CD8+ memory T cells; however, the memory T cell pool
decreased over time (44,45), as bystander proliferation fails to
occur. Wild-type memory CD8+ T cells transferred into IL-152/2
mice do not proliferate and disappear rapidly (46). Over-
expression of IL-15 increased the numbers of memory CD8+
cells (47,48). In the lean mice, Il15 mRNA expression was
maintained at a constant level; however, expression of mRNA
for Il15 in the obese mice was ~30 times greater at d 84 p.i.
compared d 33. This increase in Il15 mRNA did not result in
increased TEM. In fact, fewer TEM were found in the obese lung.
Several possibilities may explain this finding. For example, a
reduction in IL-15R may result in decreased TEM even under
conditions of increased IL-15 expression. The IL-15R consists of
high-affinity IL-15Ra, IL-2/15Rb (CD122), and gc subchains
that form a heterotrimeric receptor complex. Memory CD8+ T
cells express high levels of CD122. Obese, but not lean, Zucker
rats have significantly decreased expression of mRNA for the gc
and CD122 subunits of the IL-15 receptor whereas IL-15Ra
remained unchanged (49). Whereas the mRNA expression of
Il2Rb and Il15ra in the lungs of lean and obese mice did not
differ (data not shown), the numbers of TEM expressing CD122
were significantly reduced in the lungs of DIO mice 33 d post
primary infection. In addition, the mean fluorescence intensity of
CD122 was also significantly reduced on TEM expressing the
receptor, indicating a decreased amount of expression on these
cells. However, by d 84, CD122 expression did not differ
between lean and obese mice. Therefore, alterations in IL-15R
levels likely do not account for the decrease in TEM. In addition,
it should be noted that our study measured mRNA levels for IL-
15, which may not accurately reflect protein levels.
A second possibility for decreased TEM in the presence of
increased IL-15 levels is a blockade of IL-15 action due to leptin
resistance. Elevated levels of leptin in the obese state results in
attenuated central leptin signaling, with likely decreased signal-
ing in the periphery as well. Leptin, IL-7, and IL-15 share
structural homology and signal through the Janus Kinase-signal
transducer and activator of transcription (STAT) pathway. IL-15
has been found to play a role in lipid metabolism, fat deposition,
and insulin sensitivity. Recently, IL-15 administration to healthy
lean rodents was found to reduce white adipose deposition
without changing food consumption (50,51). Mice overexpress-
ing IL-15 exhibit reduced body fat and increased resistance to
DIO (51–53). IL-15 administration to obese leptin-deficient (ob/
ob) mice, but not Lepr-deficient obese (fa/fa) rats, resulted in
decreased fat deposition. Thus, leptin signaling appears to be
very important for the function of IL-15. In the lungs of obese
mice, LeprmRNA expression was significantly decreased at d 33
p.i. and did not increase over time as in lean controls, suggesting
that leptin signaling was likely impaired.
Besides Il15mRNA expression, the obesigenic state may affect
other aspects of IL-15 function. Trans-presentation of IL-15 by
antigen-presenting cells, particularly DC, has been shown to
be very important for memory T cell maintenance. IL-15 is bound
to IL-15Ra on the surface of the DC and stimulates neighboring
cells through the CD122/gc complex (50–53). Because previous
studies in our laboratory (32) and others (54,55) have shown
DC functionality is affected by obesity and alterations in leptin
signaling, decreased IL-15 trans-presentation by DC could
contribute to the decreased memory cell maintenance in the lungs
of obese mice.
Characteristic of leptin resistance, mRNA expression of
Socs1 and Socs3, potent inhibitors of Janus Kinase-STAT
signaling, were significantly increased in the lungs of obese
mice. The participation of SOCS proteins, particularly SOCS-3
but also SOCS-1, as negative-feedback regulators of leptin
signaling has been suggested as a causal factor for central leptin
resistance (56–58). Indeed, SOCS-3 deficiency elevates leptin
sensitivity and confers resistance to diet-induced obesity (59,60).










Fold of control 2
Il15 1.00 6 0.62 0.73 6 0.45 6.46 6 3.25 28.9 6 9.39a,b
Il7 1.00 6 0.43 0.20 6 0.08a 4.11 6 1.94b 3.13 6 1.17b
Lepr 1.00 6 0.33 0.35 6 0.10a 2.69 6 0.78b 1.53 6 0.49
Socs1 1.00 6 0.26 1.55 6 0.31 1.61 6 0.23 3.87 6 0.86a,b
Socs3 1.00 6 0.27 1.40 6 0.73 2.18 6 0.97 6.72 6 2.41a,b
Tnfa 1.00 6 0.50 3.23 6 0.86a 0.63 6 0.09 4.53 6 2.16a
Il6 1.00 6 0.56 4.96 6 2.45 1.64 6 1.18 8.82 6 3.26a
1 Values are means6 SEM, n = 5–6. Letters indicate differences (P , 0.05): a vs. lean;
b vs. d 33 pi.
2 Data were normalized to b-actin and expressed relative to lean, d 33 p.i.
FIGURE 3 Percentage (A), count (B), and mean fluorescence
intensity (C ) of CD122 expression on influenza-specific TEM cells in
lungs of lean and obese mice at d 33 and 84 p.i. CD122 expression on
TEM cells (CD8
+/DbNP366–74
+/CD44+/CD62L2) was identified using flow
cytometry. In B, data were obtained on d 33 p.i. Data are means + SEM,
n = 6. Symbols indicate differences (P , 0.05): * vs. lean; § vs. d 33.
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Both SOCS-1 and SOCS-3 can inhibit Lepr signaling (61,62).
SOCS proteins are induced upon cytokine stimulation and
attenuate signaling by various cytokine receptors, allowing
possible cross-regulation among several cytokine systems. For
example, SOCS-3 is induced by IL-2, IL-6, and leptin and can
inhibit leptin, IL-2, IL-4, IL-6, IFNa/b, and IFNg signaling (63–
67). Although SOCS-3 has not yet been directly linked to IL-15
signaling, it has been observed that SOCS-1 expression can
directly regulate IL-15–driven homeostatic proliferation and
SOCS-12/2 mice accumulate CD44+/CD8+ memory phenotype
T cells, which express elevated levels of CD122 (68,69). We
observed a decrease in the numbers of CD44+/CD8+ memory T
cells in obese mice despite an increase in Il15mRNA expression.
Therefore, the increased SOCS expression in the lungs due to
leptin resistance could be responsible for the failure of IL-15 to
signal, thereby preventing the bystander proliferation required
for memory T cell maintenance and resulting in a significantly
reduced, lung-resident TEM population over time.
Obesity has also been associated with chronic inflammation
and, indeed, significant increases in Il6 and tumor necrosis factor
(TNF)-a (Tnfa) mRNA expression were seen in the lungs of
obese mice at d 33 and d 84 p.i. Although increased adipose
tissue and serum levels of TNFa and IL-6 have been reported
previously (5,70–74), our work demonstrates that chronic
inflammation can also occur in the lungs of obese mice. This
increased inflammation has been associated with leptin resis-
tance, because these cytokines could contribute to or be the
result of upregulation of SOCS proteins (75). Indeed, Socs1
mRNA expression has been found to attenuate IFN-dependent
signaling pathways as well as insulin signaling (76,77). Inability
to regulate signaling in these pathways in obese mice could be
important for the generation of chronic inflammation and
altered type I IFN (IFNI) responses seen in the DIOmice (24,27).
IFNI appears to be very important for the production of the
basal level of IL-15. IFNI receptor-deficient mice have one-half
as many CD122hi memory cells compared with normal C57BL/6
controls. This is even more pronounced in STAT1-deficient mice,
which are unresponsive to both IFNI and IFNg (42).
Although maintenance of memory T cell populations is
regulated by IL-15 and IL-7, other factors could contribute to
the reduction in the numbers of influenza-specific TEM in the
lungs of obese mice over time. Both IL-15 and IL-7 increase the
resistance of memory T cells to apoptosis, allowing them to
persist for long periods of time. Interestingly, leptin signaling can
also be attributed to reduction of T cell apoptosis, because leptin
treatment has been found to prevent the decline of T cell
numbers in the fasted state (78). If memory T cells in the lungs of
obese mice are leptin resistant, then memory cells in the
obesigenic environment would be at increased sensitivity to
inflammation-induced apoptosis.
DIO mice are able to generate influenza-specific memory
CD8+ T cells; however, the functional capability of these cells
(24) and their ability to be maintained in the lung is significantly
reduced. The understanding of memory T cell maintenance is
still in its infancy; however, it is clear that IL-15 and IL-7 and
their subsequent signals are important for maintaining the
memory cell population over time. Our study has shown that
diet-induced obesity can affect the maintenance of influenza-
specific memory T cell populations in the lungs. This decrease in
memory T cell numbers may be due to peripheral leptin
resistance in the obesigenic lung microenvironment affecting
IL-15 function. Overall, decreased numbers of TEM over time,
coupled with the decreased functional capability of these cells,
suggests that obesity presents an even greater risk to increased
morbidity and mortality from infection with a heterologous
pandemic strain. Indeed, vaccine strategies that promote the
generation of memory T cells may be less effective in an obese
population.
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